Pioglitazone
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names: Pioglitazona, Pioglitazone Hydrochloride, Pioglitazone, Pioglitazonum, pioglitazone HCl, Actos, Actost, Glustin
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Dosing and Administration
Monotherapy
ACTOS monotherapy in patients not adequately controlled with diet and exercise may
be initiated at 15 mg or 30 mg once daily. For patients who respond inadequately to the
initial dose of ACTOS, the dose can be increased in increments up to 45 mg once daily.
For patients not responding adequately to monotherapy, combination therapy should be
considered.
For more information on dosing please refer to Instructions for administration
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Pioglitazone
Return to top
Publication Resources
Most Recent Articles on Pioglitazone
Review Articles on Pioglitazone
Articles on Pioglitazone in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Pioglitazone
Return to top
Trial Resources
Ongoing Trials with Pioglitazone at Clinical Trials.gov
Trial Results with Pioglitazone
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Pioglitazone
Cochrane Collaboration on Pioglitazone
Cost Effectiveness of Pioglitazone
Return to top
Media Resources
Powerpoint Slides on Pioglitazone
Images of Pioglitazone
Podcasts & MP3s on Pioglitazone
Videos on Pioglitazone
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Pioglitazone
Discussion Groups on Pioglitazone
Patient Handouts on Pioglitazone
Blogs on Pioglitazone
Pioglitazone in the News
Pioglitazone in the Marketplace
Return to top
International Resources
Pioglitazone en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
